Pegylated liposomal doxorubicin (CAELYX)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated liposomal doxorubicin (CAELYX), covering 2015-12-17 to 2015-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) [NA]